GET THE APP

A Tubulocentric Insight into Diabetic Kidney Disease: Unveiling the Role of Renal Tubules
..

Journal of Formulation Science & Bioavailability

ISSN: 2577-0543

Open Access

Perspective - (2023) Volume 7, Issue 1

A Tubulocentric Insight into Diabetic Kidney Disease: Unveiling the Role of Renal Tubules

David Coelho*
*Correspondence: David Coelho, Department of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK, Email:
Department of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK

Received: 03-Jan-2023, Manuscript No. FSB-23-101962; Editor assigned: 05-Jan-2023, Pre QC No. P-101962; Reviewed: 17-Jan-2023, QC No. Q-101962; Revised: 23-Jan-2023, Manuscript No. R-101962; Published: 30-Jan-2023 , DOI: 10.37421/2577-0543.2023.7.150
Citation: Coelho, David. “A Tubulocentric Insight into Diabetic Kidney Disease: Unveiling the Role of Renal Tubules.” J Formul Sci Bioavailab 7 (2023): 150.
Copyright: © 2023 Coelho D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is a serious complication that affects a significant number of individuals with diabetes. It is a leading cause of end-stage renal disease worldwide. Traditionally, DKD has been viewed as a glomerulocentric disorder, with emphasis on the damage occurring in the renal glomeruli. However, emerging research has shed light on the crucial role of renal tubules in the pathogenesis and progression of DKD. This article aims to explore the tubulocentric perspective of DKD, unveiling the intricate interplay between renal tubules and disease progression. They actively participate in inflammation, fibrosis, and immune responses, making them key players in the pathogenesis of DKD. Under diabetic conditions, renal tubules experience profound alterations in structure and function, leading to tubular injury, interstitial inflammation, and progressive fibrosis. Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is a leading cause of end-stage renal disease worldwide [1]. While it is well-established that diabetes mellitus damages the kidneys, recent research has shed light on the critical role of renal tubules in the development and progression of DKD. Traditionally, glomerular dysfunction was believed to be the primary driver of DKD, but emerging evidence suggests that tubular injury plays a pivotal role in the pathogenesis of this debilitating condition. In this article, we explore the tubulocentric perspective of DKD and discuss the key mechanisms involved in renal tubule injury.

Description

Renal tubules

Renal tubules, found in the kidney's cortical and medullary regions, play a pivotal role in kidney function by reabsorbing filtered solutes and regulating fluid balance. In DKD, multiple mechanisms can lead to tubular injury and dysfunction. The hallmark feature of tubular damage is the presence of tubulointerstitial fibrosis, characterized by the accumulation of extracellular matrix proteins, inflammation, and tubular atrophy [2].

Glucose and proximal tubular injury

Elevated blood glucose levels in diabetes can directly affect the renal proximal tubules. Glucose is reabsorbed in the proximal tubules through the sodium-glucose cotransporter 2 (SGLT2). In diabetes, increased glucose reabsorption and subsequent intracellular metabolism lead to tubular hypertrophy, oxidative stress, and mitochondrial dysfunction. These processes contribute to the development of tubulointerstitial fibrosis.

Tubular hypoxia and endothelial dysfunction

DKD is associated with alterations in renal hemodynamics, including glomerular hyperfiltration and intrarenal vasoconstriction. These changes can result in reduced oxygen delivery to the renal tubules, leading to tubular hypoxia. Tubular hypoxia, in turn, activates Hypoxia-Inducible Factors (HIFs), triggering a cascade of events that promote fibrosis, inflammation, and endothelial dysfunction. Endothelial dysfunction further impairs renal blood flow regulation and exacerbates tubular injury.

Albuminuria and tubular inflammation

Albuminuria, the leakage of albumin into the urine, is a classic marker of glomerular dysfunction in DKD. However, recent studies have highlighted the contribution of renal tubules to albuminuria and subsequent tubular inflammation. The reabsorption of filtered albumin by proximal tubular cells activates intracellular signaling pathways, such as the nuclear factor kappa B (NF-κB) pathway, leading to the production of pro-inflammatory cytokines. This tubulocentric inflammation perpetuates the progression of DKD [3].

Renal tubules as modulators of Renin-Angiotensin-Aldosterone System (RAAS)

The Renin-Angiotensin-Aldosterone System (RAAS) plays a crucial role in regulating blood pressure and fluid balance. In DKD, the renal tubules actively participate in the local production and activation of components of the RAAS. Tubular epithelial cells express Angiotensin-Converting Enzyme (ACE) and angiotensin II receptors, allowing for the amplification of the RAAS within the tubulointerstitium. The local activation of RAAS contributes to tubular inflammation, fibrosis, and oxidative stress, perpetuating renal damage.

Therapeutic implications

Understanding the tubulocentric aspects of DKD opens up new avenues for therapeutic interventions. Targeting specific mechanisms of tubular injury, such as glucose reabsorption via SGLT2 inhibitors or HIF activation, holds promise in preventing or halting the progression of DKD. Additionally, modulating tubular inflammation and fibrosis through anti-inflammatory agents and profibrotic mediators might provide additional therapeutic strategies [4,5].

Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is one of the most common and debilitating complications of diabetes mellitus. It affects a significant portion of diabetic individuals and often progresses to end-stage renal disease, necessitating dialysis or kidney transplantation. Historically, DKD has been primarily understood as a glomerular disease, with a strong focus on the role of the renal glomeruli in disease pathogenesis. However, emerging research has highlighted the pivotal contribution of renal tubules in the development and progression of DKD. This article aims to provide a tubulocentric insight into DKD, shedding light on the intricate involvement of renal tubules and their potential as therapeutic targets.

Conclusion

Shifting the focus to the tubulocentric perspective of DKD allows for a more comprehensive understanding of the disease pathogenesis and progression. Renal tubules are not merely passive conduits but active contributors to the development and perpetuation of DKD. Elucidating the intricate interplay between tubular injury, inflammation, and fibrosis provides a foundation for the development of targeted therapies aimed at preserving renal function and improving outcomes for individuals with DKD. Renal tubules, constituting the bulk of the kidney's nephrons, have long been recognized for their role in reabsorption and secretion of solutes and water. However, recent studies have revealed that tubular cells possess diverse functions that extend beyond their traditional role in electrolyte balance.

References

  1. Duan, Suyan, Fang Lu, Dandan Song and Chengning Zhang, et al. "Current challenges and future perspectives of renal tubular dysfunction in diabetic kidney disease." Front Endocrinol 12 (2021): 661-185.
  2. Google Scholar, Crossref, Indexed at

  3. Yang, Yan-Lin, Meng Xue, Yi-Jie Jia and Fang Hu, et al. "Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway." Exp Mol Med 52 (2020): 266-280.
  4. Google Scholar, Crossref, Indexed at

  5. Kim, Sang Soo, Jong Ho Kim, Su Mi Lee and Il Young Kim, et al. "New Tubulocentric Insights for diabetic nephropathy: From pathophysiology to treatment." Adv Nephr (2018).
  6. Google Scholar, Crossref, Indexed at

  7. Gao, Peng, Ming Yang, Xianghui Chen and Shan Xiong, et al. "DsbA-L deficiency exacerbates mitochondrial dysfunction of tubular cells in diabetic kidney disease." Clin Sci 134 (2020): 677-694.
  8. Google Scholar, Crossref, Indexed at

  9. Cai, Ting, Qingqing Ke, Yi Fang and Ping Wen, et al. "Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice." Cell Death Dis 11 (2020): 390.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 23

Journal of Formulation Science & Bioavailability received 23 citations as per Google Scholar report

Journal of Formulation Science & Bioavailability peer review process verified at publons

Indexed In

arrow_upward arrow_upward